Should Antileukotriene Therapies Be Used Instead of Inhaled Corticosteroids in Asthma?
- 1 December 1998
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 158 (6) , 1697-1698
- https://doi.org/10.1164/ajrccm.158.6.15860
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- The Role of Leukotriene Modifiers in the Treatment of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Leukotriene modifiers in the treatment of asthmaBMJ, 1998
- Pulmonary Infiltrates, Eosinophilia, and Cardiomyopathy Following Corticosteroid Withdrawal in Patients With Asthma Receiving ZafirlukastJAMA, 1998
- A Comparison of Beclomethasone, Salmeterol, and Placebo in Children with AsthmaNew England Journal of Medicine, 1997
- Antileukotrienes in the Treatment of AsthmaAnnals of Internal Medicine, 1997
- Effectiveness of the Leukotriene Receptor Antagonist Zafirlukast for Mild-to-Moderate AsthmaAnnals of Internal Medicine, 1997
- ZileutonThe Lancet, 1996
- The role of leukotrienes in asthma and allergic rhinitisClinical and Experimental Allergy, 1996
- Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapyJournal of Allergy and Clinical Immunology, 1996
- Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network.American Journal of Respiratory and Critical Care Medicine, 1996